C.C. Abbou - Concepedia

Author

C.C. Abbou

Centre Hospitalier Universitaire Henri-Mondor

Also Known As

C ABBOU, C Abbou, C C Abbou, C. ABBOU, C. Abbou, C. C. ABBOU, C. C. Abbou, C.-C. Abbou, C.C Abbou, C.C. ABBOU

230

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire Henri-Mondor Inserm Hôpitaux Universitaires Henri-Mondor Université Paris-Est Créteil Assistance Publique – Hôpitaux de Paris

About

C.C. Abbou is an author at Centre Hospitalier Universitaire Henri-Mondor specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	39	3.2K
2	Blood Transplantation	2	2	29
3	Health Sciences	1	1	30
4	Cell Biology	1	1	31
5	Cellular Physiology	1	1	31

C.C. Abbou

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience Jean‐Jacques Patard, Emmanuelle Leray, Nathalie Rioux‐Leclercq, Journal of Clinical Oncology	2005	750
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors C Billerey, Dominique Chopin, Marie‐Hélène Aubriot‐Lorton, American Journal Of Pathology UrologyPerineural InvasionGenitourinary CancerFrequent Fgfr3 MutationsSurgical Pathology	2001	477
Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study Jean‐Jacques Patard, Hyung L. Kim, John S. Lam, Journal of Clinical Oncology	2004	416
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Ashraf Bakkar, Hervé Wallerand, François Radvanyi, PubMed PathologyTumor BiologyGenitourinary CancerCancer Cell BiologyFibroblast Growth Factor	2003	272
Regional copy number–independent deregulation of transcription in cancer Nicolas Stransky, Céline Vallot, Fabien Reyal, Nature Genetics Transcriptional RegulationGeneticsCancer GenomicsCancer GeneticsGene Expression	2006	253
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy Luca Cindolo, Jean‐Jacques Patard, Paolo Chiodini, Cancer	2005	215
Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication Jean‐Jacques Patard, Allan J. Pantuck, Maxime Crépel, European Urology UrologySurgical OncologyGenitourinary CancerMedicineMinimally Invasive Procedure	2007	212
MORBIDITY AND CLINICAL OUTCOME OF NEPHRON-SPARING SURGERY IN RELATION TO TUMOUR SIZE AND INDICATION J.-J. Patard, Maxime Crépel, Allan J. Pantuck, European Urology Supplements UrologySurgical OncologyGenitourinary CancerMedicineMinimally Invasive Procedure	2006	189
Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized Trial R.A. Janknegt, C.C. Abbou, Riccardo Bartoletti, The Journal of Urology	1993	182
The Learning Curve for Laparoscopic Radical Prostatectomy: An International Multicenter Study Fernando P. Secín, Caroline Savage, C.C. Abbou, The Journal of Urology	2010	140

Page 1